Stay updated on Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page's version history.
    Difference
    0.1%
    Check dated 2026-03-19T04:41:21.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Updated the page revision from v3.4.2 to v3.4.3 in the footer.
    Difference
    0.1%
    Check dated 2026-03-12T00:00:28.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.2 was added and the previous revision notice v3.4.1 along with the government-funding/operating status notice were removed.
    Difference
    0.5%
    Check dated 2026-02-11T12:18:38.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and updated operation status guidance. Updated the page version from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:47:48.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The changes include adding a glossary display option, updating the wording of QC-related fields (Last Update Submitted that Met QC Criteria) and capitalization for No FEAR Act Data, and introducing the Revision: v3.4.0 indicator. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:25:14.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    The page revision updated from v3.3.3 to v3.3.4; this is minor metadata with no visible changes to the study’s content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:49:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.